January 15, 2026 | Generative AI, Intelligent Commercialization
Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on, confidence-building practice for Medical Affairs and Commercial teams.

In this webcast, Inizio examine why traditional, analog models of training are no longer enough in an environment where HCPs have less time, higher expectations, and demand both scientific depth and concise value. You’ll gain an understanding of the evolving “menu” of AI-enabled upskilling options, what truly differentiates those that drive measurable impact, and a practical framework to evaluate and integrate these capabilities into your own field development strategy.
Watch now to learn how Inizio delivers AI-enabled field training through Intelligent Commercialization™ and how this approach can elevate the effectiveness of your Medical and Commercial teams.
This content was provided by Inizio
Latest Content from Inizio
Published in eyeforpharma January 2017 by Mariel Metcalfe
Published in Pharmaphorum January 2017
We are delighted to be attending and presenting a paper at the EphMRA one day meeting on Tuesday 21st February, in London
Why would a pharma company want to carry out a segmentation study? What are some of the challenges? Head of Business Analytics Tom Nolte and Associate Director Dr Marianne Jaeger…
We are delighted to be exhibiting and presenting a paper at the Pharmaceutical Market Research Conference 1-2 February in Parsippany, NJ.
Our client was planning to launch an over-the-counter (OTC) probiotics product for the purposes of improving IBS management and wanted to understand current perceptions, practices and usage amoungst a range…
Published in eyeforpharma December 2016 by Marc Yates
Research Partnership has made a seasonal donation of US$5,000 to our chosen charity, Forever Projects
The ideal route of admin isn’t clear cut in the global marketplace
In this paper, we will explore the chronic disease patient journey in emerging markets and provide you with the insights you require to identify the key inflection points in these…
